Trump’s Drug Firms Stocks Benefiting From Medicare Carveout, Democrats Say
Trump’s Drug Firms Stocks Benefiting From Medicare Carveout, Democrats Say/ TezzBuzz/ WASHINGTON/ J. Mansour/ Congressional Democrats say investments made on President Donald Trump’s behalf expanded sharply in drugmakers benefiting from Medicare price-negotiation exemptions. Their report raises concerns about potential conflicts and higher patient costs, while the White House says independent institutions manage his portfolio without … Read more